A phase 2 study has suggested that the glycoprotein (gp) IIb/IIIa blocker eptifibatide can be safely combined with a reduced dose of tPA in the treatment of acute ischemic stroke, and there was a ...
A study evaluating a new approach using a combination of two thrombolytics designed to reduce bleeding risk in patients with acute ischemic stroke has not shown any benefit on the primary outcome of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback